亞培
ABT124.670USD
+0.240+0.19%
收盤 10/30, 16:00（美東）報價延遲15分鐘
216.79B總市值
15.51本益比TTM
關於 亞培 公司
亞培是一家橫跨全球的醫療保健領導者，專注於多元健康產品的研發、製造與銷售，業務框架涵蓋四大單元：成熟藥品、診斷、營養以及醫療器械。成熟藥品單元負責多品牌仿製藥的國際行銷；診斷單元向血庫、醫院、商業實驗室與替代護理點提供檢測系統與試劑；營養單元經營成人及兒童營養品全球通路；醫療器械單元銷售節律管理、電生理、心衰、血管、結構心臟、神經調控及糖尿病護理裝置，持續推動創新改善患者生命品質。其全球供應鏈覆蓋六大洲，利用數據分析與可持續製造提升效率與品質保障。
亞培簡介
公司代碼ABT
公司名稱Abbott Laboratories
上市日期Mar 01, 1937
CEOMr. Robert B. Ford
員工數量114000
證券類型Ordinary Share
年結日Mar 01
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NYSE Consolidated
國家United States of America
郵編60064-3500
電話12246676100
網址https://www.abbott.com
公司代碼ABT
上市日期Mar 01, 1937
CEOMr. Robert B. Ford
亞培公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-0.75%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Diabetes Care
1.98B
17.78%
Core Laboratory
1.36B
12.19%
Adult Nutritionals
1.16B
10.39%
Key Emerging Markets
1.06B
9.50%
Pediatric Nutritionals
1.05B
9.46%
其他
4.53B
40.67%
地區USD
名稱
營收
佔比
All other Countries
6.87B
61.62%
United States
4.28B
38.38%
業務
地區
業務USD
名稱
營收
佔比
Diabetes Care
1.98B
17.78%
Core Laboratory
1.36B
12.19%
Adult Nutritionals
1.16B
10.39%
Key Emerging Markets
1.06B
9.50%
Pediatric Nutritionals
1.05B
9.46%
其他
4.53B
40.67%
股東統計
更新時間: 8月15日 週五
更新時間: 8月15日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.89%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Investment Management (US)
4.51%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
其他
74.65%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.89%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Investment Management (US)
4.51%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
其他
74.65%
股東類型
持股股東
佔比
Investment Advisor
46.33%
Investment Advisor/Hedge Fund
22.98%
Research Firm
3.62%
Bank and Trust
2.25%
Pension Fund
2.21%
Sovereign Wealth Fund
1.37%
Insurance Company
1.06%
Individual Investor
0.48%
Hedge Fund
0.44%
其他
19.25%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
4555
1.40B
80.58%
-14.37M
2025Q2
4616
1.41B
81.28%
+6.94M
2025Q1
4644
1.42B
81.42%
+12.91M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
172.03M
9.88%
+2.96M
+1.75%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
88.52M
5.09%
+696.11K
+0.79%
Jun 30, 2025
State Street Investment Management (US)
78.35M
4.5%
+689.52K
+0.89%
Jun 30, 2025
Capital International Investors
60.14M
3.46%
-6.69M
-10.01%
Jun 30, 2025
Capital Research Global Investors
41.77M
2.4%
-8.97M
-17.68%
Jun 30, 2025
Geode Capital Management, L.L.C.
38.29M
2.2%
+1.39M
+3.77%
Jun 30, 2025
JP Morgan Asset Management
26.38M
1.52%
-2.42M
-8.39%
Jun 30, 2025
Wellington Management Company, LLP
25.05M
1.44%
-4.71M
-15.83%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
22.25M
1.28%
+1.27M
+6.03%
Jun 30, 2025
Wells Fargo Advisors
15.18M
0.87%
-240.50K
-1.56%
Jun 30, 2025
查看更多
持股ETF
更新時間: 10月2日 週四
更新時間: 10月2日 週四
機構名稱
佔比
iShares U.S. Medical Devices ETF
18.52%
Goldman Sachs Future Health Care Equity ETF
6.46%
SMI 3Fourteen Full-Cycle Trend ETF
5.18%
Tema Heart & Health ETF
4.68%
Health Care Select Sector SPDR Fund
4.64%
Proshares Ultra Health Care
4.64%
iShares U.S. Healthcare ETF
4.44%
AdvisorShares Focused Equity ETF
4.42%
Invesco Pharmaceuticals ETF
4.35%
Polen Capital Global Growth ETF
4.27%
查看更多
iShares U.S. Medical Devices ETF
佔比18.52%
Goldman Sachs Future Health Care Equity ETF
佔比6.46%
SMI 3Fourteen Full-Cycle Trend ETF
佔比5.18%
Tema Heart & Health ETF
佔比4.68%
Health Care Select Sector SPDR Fund
佔比4.64%
Proshares Ultra Health Care
佔比4.64%
iShares U.S. Healthcare ETF
佔比4.44%
AdvisorShares Focused Equity ETF
佔比4.42%
Invesco Pharmaceuticals ETF
佔比4.35%
Polen Capital Global Growth ETF
佔比4.27%
分紅派息
近5年累計派現
16.46B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
